Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
108 participants
INTERVENTIONAL
2022-07-14
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Expressive Helping for Chinese-Speaking Cancer Patients and Survivors
NCT03945734
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study
NCT04754412
Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors
NCT02946619
Health Benefits of Expressive Writing: Study One
NCT03546673
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
NCT06782581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Expressive Helping
Participants complete a 20-minute expressive writing session once per week for the first three weeks. During Week 4, participants complete a 20-minute peer support writing session.
Expressive Helping
Expressive helping involves a combination of emotional disclosure and peer support writing completed over four weeks.
Expressive Writing
Participants complete a 20-minute expressive writing session once per week for four weeks.
Expressive Writing
Expressive writing involves emotional disclosure writing over four weeks.
Factual Writing
Participants complete a 20-minute factual writing about their cancer diagnosis and treatment every week for four weeks.
Factual Writing
Factual writing involves writing facts about cancer treatment and experiences over four weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Expressive Helping
Expressive helping involves a combination of emotional disclosure and peer support writing completed over four weeks.
Expressive Writing
Expressive writing involves emotional disclosure writing over four weeks.
Factual Writing
Factual writing involves writing facts about cancer treatment and experiences over four weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prefer speaking in Mandarin Chinese or Cantonese, and able to read and write Simplified or Traditional Chinese.
* Within 5 years after completing primary treatment or have completed primary treatment but still on medication for managing cancer-related symptoms.
Exclusion Criteria
* Current active participation in support groups (i.e., attending more than once per week)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York University
OTHER
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-0603
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.